Does your company need D & O Insurance?
Recently, a small business owner decided it was time to put a board of directors in place for his company. After several years of growth, the owner felt a board could help focus the company’s direction. Upon learning this, several people mentioned that it was prudent to get directors and officers liability insurance.
Directors, officers, and organizations are held accountable to investors and shareholders for the financial management of the company they work for. They take strategic risks for the growth of the business. Sometimes the choices they make can impact the business negatively, which can put them at risk of being sued. This insurance can be key to your business’s risk management plan.
If you are running a public company Directors and Officers Insurance could be the deciding factor in bringing on a qualified Director.
D & O Insurance demonstrates your professionalism and ensures you’ll have protection and world class representation if you and your fellow directors are ever sued.
Get a Free Quote from a Commercial Insurance Representative in Minutes!
Don’t feel like filling in a form?
Skip ahead of the line and call toll-free: 405-829-6978
Weekly Update: August 9th, 2022
Everyone is hanging on wondering about tomorrow’s inflation news. To me a very big overhang on the market is the “China” situation. While they are busy threatening neighbors and we are providing them the trillions of dollars in trade to back their bluster, our leaders seem to have taken their eye off the ball.
It’s going to be painful but we have to get back to made in America and be prepared to drop China on its head economically if they persist in their global empire building. No small part of that is buying their way into countries around the world including ours. They have become a major threat and we have been asleep at the wheel while they are stealthily stealing our technologies and buying their way into our best Universities. For damn sure we can’t be standing with our hand out waiting on computer chips.
Yahoo Finance 8-9-22
Tech leads stocks lower ahead of July CPI print
U.S. stocks extended losses Tuesday as investors assessed earnings and prepared for a key inflation report due out Wednesday.
The S&P 500 fell 0.4%, while the Dow Jones Industrial Average ticked down about 0.2%. The tech-heavy Nasdaq Composite tumbled 1.2% as a warning from Micron Technology (MU) weighed on chip and technology stocks.
Shares of Micron fell 3.7% after the memory chipmaker said its fourth-quarter revenue may come in on par with or below the bottom end of a forecast range provided in the company’s earnings call June 30.
Micron’s announcement comes one day after chip industry peer Nvidia (NVDA) indicated its second-quarter revenue would drop by 19% from the prior quarter as the gaming business more broadly takes a hit from fewer purchases by consumers of discretionary items such as laptops and video game consoles.
The 21st Century Investment Bank Capital Raises + Strategic Advisory
Donald Capital is a boutique Investment Bank that focuses on raising capital for emerging growth companies in the U.S. and around the globe.
Ideally, we like to work with Private and Public companies with a good management team, a compelling business plan, and the ability to gain market share.
For more information go to: www.DonaldCapital-NY.com
The Premier Operating System for Publicly Traded Companies
Track your investors’ buying and selling behaviors and use those insights to engage them across marketing channels.
Know who’s buying and selling and monitor trading in real time. Unlock your shareholders contact info and build full contact profiles on your shareholders, including emails, phone numbers, and social media accounts to engage them and target new investors through media campaigns.
To schedule a demo email me at firstname.lastname@example.org or call 727-459-7378
7-25-2022 International Food and Beverage (OTC IFBC)
IFBC Joins SRAX Platform
PLAINVIEW, NY / ACCESSWIRE / July 25, 2022 /Italian Food & Beverage Corp. (OTC Pink:IFBC) Is pleased to announce that it has joined the SRAX Premier Operating System for Publicly Traded Companies. The benefits to IFBC from this arrangement extend from the fostering of the IFBC brand to potential investors, to creating an awareness of IFBC and its products to beverage distribution companies and other marketing channels across the entire USA. SRAXInc. is a NASDAQ company, which, by way of its sophisticated financial technology, unlocks valuable data and insightful nuances of the shareholder bases for publicly traded companies. With its premier investor intelligence and communications platform, Sequire, through which companies can carefully track their investors’ behaviors, trends, and patterns, and use those insights to engage current and potential investors across a host of marketing channels.
07-26-2022 CanB Corp (OTC CANB)
Can B Corp. Inks Manufacturing & Distribution Agreement for Superfood Products with Forever Brands and Brooke Burke via BB Body, Inc.
Initial 3-Year Worldwide Agreement
HICKSVILLE, NY, July 26, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – Can B Corp. (OTCQB: CANB) (“Can B” or the “Company”), a health and wellness company specializing in developing, producing, and selling hemp-derived cannabinoid products and other wellness products and programs, is pleased to announce the signing of a Manufacturing and Distribution Agreement with Forever Brands to produce a line of nutritional Superfoods drink mix for Brooke Burke and her company, BB Body, Inc.
The initial 3-year worldwide agreement covers the sale, manufacturing and distribution of the Superfood and related nutritional products. Can B subsidiaries Imbibe Wellness Solutions is the exclusive direct to consumer seller of the products and Pure Health Products is a manufacturer and distributor of the products. The products will be marketed under the Longevity by Brooke Burke trademarks and brand. The partnership includes a powdered drink superfood mix, all-natural metabolic energy drink and other products that may be mutually agreed from time to time.
7-8-2022 Antibe Therapeutics, Inc. (OTCQX: ATBPF Toronto: ATE.TO)
Phase 2 Post-Operative Pain Program to Initiate in Calendar 4Q22…
Phase 2 Post-Operative Pain Program to Initiate in Calendar 4Q22
Antibe Therapeutics, Inc. (OTC:ATBPF) (TSX:ATE.TO) is developing otenaproxesul as a solution to the dose-related gastrointestinal (GI) side effects associated with non-steroidal anti-inflammatory drugs (NSAIDs). It uses naproxen as a base molecule with a hydrogen sulfide moiety covalently attached. Hydrogen sulfide (H2S) is an important gasotransmitter, which is a gas that serves as an important signaling molecule in the body.
The company is developing otenaproxesul for the management of acute pain, with an initial indication of post-operative pain. The most recent pharmacokinetic/pharmacodynamic (PK/PD) study conducted by Antibe examined various loading doses of otenaproxesul. The results from this study suggests that the drug has a potentially rapid onset of action that would be necessary for an acute pain treatment.
Very Coool new Pre-IPO Offering Launch
COLORADO SPRINGS, Colo., June 13 — Today, Notes Live is announcing its pre-IPO offering. Notes Live will be raising $22,500,000 in the sale of 1,500,000 class B non-voting common shares at $15 per share. The company plans to file an S-1 with the Securities and Exchange Commission in the fourth quarter of 2022 in which these shares will be registered.
The offering will be made only to accredited investors under Rule 506(c) of Regulation D. The private placement memorandum relating to the offering may be obtained from either Donald Capital or the Company at Invest – (noteslive.vip).
Notes Live’s largest expansion to date is underway in Colorado Springs, Colorado in what will be the nation’s most luxurious music coliseum, the 8,000-seat Sunset Amphitheater. Additionally, the company has begun construction in the Northern Atlanta market on a new multi-million dollar entertainment campus covering an entire city block in downtown Gainesville, Georgia. This campus is scheduled to open in the first quarter of 2023. An 18-acre multi-concept campus is also under development in the rapidly growing city of Murfreesboro, Tennessee, Nashville’s neighbor to the south. This development includes a Bourbon Brothers Smokehouse and Tavern, a 20,000 square foot Boot Barn Hall, and 4,500 seat outdoor Sunset Amphitheater, all sitting on the Stones River. The company prides itself on its public-private partnerships and has plans to operate in a half dozen markets by the end of 2023, with expansions to six additional markets planned over the next five years.
This announcement shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. All investment involves risk and loss of principal is possible.
About Notes Live
Notes Live, founded by Colorado Springs-based entrepreneur JW Roth, is the rapidly growing live-entertainment company that by the end of 2023 will be operating a half dozen large and mid-sized premium music venues across the West and South. The company identifies areas with growing populations without a vibrant live music scene and offers premium concert experiences, complete with unbeatable sound and sightlines as well as elevated food and beverage options. It currently boasts a Colorado Springs entertainment campus with the Boot Barn Hall concert venue, Bourbon Brothers Smokehouse and Tavern, and Buttermilk breakfast eatery.
6-6-2022 SRAX (NASDAQ: SRAX)
SRAX Reports Record Full Year and Q4 2021 Financial Results
LOS ANGELES, June 06, 2022 (GLOBE NEWSWIRE) — SRAX, Inc. (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its SaaS platform, is providing full year financial results.
SRAX exceeded guidance of $31.5M for 2021, with SRAX totaling $28.6 million in revenue, and its former subsidiary, BIGtoken, totaling $3.4 million in revenue. Due to the deconsolidation of BIGtoken as of December 31, 2021, the following full year earnings report includes BIGtoken’s results from operations as discontinued operations. Due to an increase in bookings, SRAX is providing guidance of $47M-$50M for 2022.
5-31- 2022 Ecrid, Inc (OTC ECDD)
ECRID/ResMac Mortgage Strikes Deal That Can Change the Entire Credit Industry
PALM BEACH, FL , May 31, 2022 /PRNewswire/ — ECRID, Inc. (Stock Symbol: ECDD) and ResMac Mortgage have teamed up to help millions of Americans become home owners who have difficulty obtaining mortgages or refinancing existing mortgages in this current economic climate. ECRID, the new Credit Bureau offers the tools and resources to assist Americans in taking control of their financial destinies to become financially stable and build wealth. Through the ECRID platform www.ecrid.com customers can sign up and create their own ECRID Credit Report and Apply for a Mortgage through ECRID Lending Corp. and begin their journey to financial health.
5-17-2022 Coeptis Therapeutics, Inc. OTC COEP
Coeptis Therapeutics Enters into Exclusive Option Agreement with University of Pittsburgh for Rights to CAR-T Technologies Designed to Target Multiple Cancer Indications, Including Hematologic and Solid Tumors
WEXFORD, Pa., May 17, 2022 /PRNewswire/ — Coeptis Therapeutics, Inc. (OTC PINK: COEP) (“Coeptis” or “the Company”), a biopharmaceutical company developing innovative cell therapy platforms for cancer, today announced entry into an exclusive option agreement with the University of Pittsburgh for the rights to three chimeric antigen receptor T cell (CAR-T) technologies that offer the potential to address a range of hematologic and solid tumors. Among the initial cancer indications under development are pre-clinical programs targeting breast cancer and ovarian cancer. Terms of the deal were not disclosed.
The exclusive option agreement involves the intellectual property rights to three technologies jointly developed in the laboratories of Jason Lohmueller, Ph.D., Assistant Professor of Immunology; Alexander Deiters, Ph.D., Professor of Chemistry; and Olivera Finn, Ph.D., Professor of Immunology: 1) mSA2 affinity-enhanced biotin-binding CAR, 2) universal self-labeling SynNotch and CARs for programable antigen-targeting, and 3) conditional control of universal CAR-T cells through stimulus-reactive adaptors. Per the option agreement, Coeptis paid the University of Pittsburgh a non-refundable fee for the exclusive option to license the patent rights to each of the three technologies. Coeptis has until October 29, 2022, to exercise the options and pay the specified exercise considerations. The option agreement may be extended an additional six months, subject to the agreement of both parties.
Check out our latest commercial properties including an Amazing Private Island or Resort Development Property in Panama
Message me on Linkedin and check our latest commercial listings:
Please subscribe to our newsletter to get ongoing Real Estate and Alternative Investing updates:
|August 8, 2022 |
COMPANY QUOTES, LISTINGS RESEARCH AND NEWS
Coeptis Therapeutics, Inc. Ecrid, Inc (ECDD) Profile
Antibe Therapeutics, Inc (ATBPF) Profile 11/11/2018 News
Can B Corp (CANB) Profile News
Endurance Exploration Group, Ltd (EXPL) Profile 03-26/19 News
Social Reality, Inc. (SRAX) Profile News
International Food and Beverage Profile
July 27, 2022
ValuEngine Weekly Report
Best Performing ETF’s Year-to-Date 2022
July 27, 2022 by Herb Blank
The list of best performing equity ETFs in the US thus far this year has been dominated by two categories: 1. Leveraged/Inverse – almost always the case by definition and 2. Single industry/sector – including energy, utilities, defense, and insurance et al. Leveraged and inverse ETFs are short-term trading tools that are very rarely, if at all, suitable for most investors. Because these two categories are so inappropriate for many investors, what to do? Low volatility and high dividend yield funds have out performed as well and are readily accessible.
ValuEngine Capital Management LLC (VECM) is pleased to announce the addition of Jordan Kimmel to the team as the new Chief Equity Strategist and portfolio manager. VECM is a Registered Investment Advisor (RIA) that invests based on the proprietary, quantitative research produced by ValuEngine Inc. It is an important partnership between two companies: ValuEngine conducts research, and ValuEngine Capital Management LLC actively trades client funds using this research.
To subscribe to our bulletins and receive content whenever it is published, subscribe at our blog HERE
Black Swan Research Coverage and Subscription Service
Event Calendar Updates
NIBA is back
September 7-8, 2022
At the luxurious Margaritaville Hollywood Beach Resort in Hollywood, Florida
|NIBA’s upcoming Florida Conference is a one-and-a-half day fast-paced, intimate event that provides private and public issuers, regardless of size or industry, a unique platform to present their individuals stories to prospective investors, financing partners, market makers and market professionals, all experienced within the capital markets.|
The 2022 LD Micro Invitational, Hosted by SRAX, Featured Many Influential Companies – Replays Available
LOS ANGELES, June 16, 2022 (GLOBE NEWSWIRE) — SRAX, Inc. (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its SaaS platform, hosted the 2022 LD Micro Invitational, both in-person in Westlake Village, CA and virtually via their Sequire Virtual Events platform, on June 7th-9th. The conference featured 187 companies, presenting for 25 minutes each. Replays are now available for viewing.
Rocky Mountain Microcap Conference IX.
The conference was a good success with great attendance and a recap will be available soon.
Visit our homepage for up to the minute Financial News, Quotes and our Latest Black Swan Connection Newsletter
-SMM Distribution Update-
SMM Global Twitter Acct (Impressions last 30 days) 520
Direct Email * 220,000